发明名称 Recombinant phage and methods
摘要 This disclosure provided methods of cloning a phage genome. Also provided are methods of making a recombinant phage genome. In some embodiments the phage genome is engineered to comprise a heterologous nucleic acid sequence, for example a sequence comprising an open reading frame. In some embodiments the phage genome is cloned in a yeast artificial chromosome. Recombinant phage genomes and recombinant phage are also provided. In some embodiments the methods are high throughput methods such as methods of making a plurality of recombinant phage genomes or recombinant phage. Collections of recombinant phage genomes and recombinant phage are also provided.
申请公布号 US9234227(B2) 申请公布日期 2016.01.12
申请号 US201213627060 申请日期 2012.09.26
申请人 Sample6 Technologies, Inc. 发明人 Lu Timothy Kuan Ta;Koeris Michael Sandor;Chevalier Brett Smith;Holder Jason Wyatt;McKenzie Gregory John;Brownell Daniel Robert
分类号 C12N15/00;C12P19/34;C12N15/10;C12N15/81;C12N15/86 主分类号 C12N15/00
代理机构 Cooley, LLP 代理人 Cooley, LLP ;Elrifi Ivor;Pavao Matthew
主权项 1. A method of making a recombinant phage genome, comprising: (a) selecting a starting phage genome and a eukaryotic vector; (b) selecting a stitching oligonucleotide or oligonucleotide duplex for recombination with the starting phage genome and the eukaryotic vector comprising: (i) detecting an imperfect oligo repeat at an end of the starting phage genome, and selecting a stitching oligonucleotide comprising a sequence from the ends of the starting phage genome and a sequence flanking the double strand break in the eukaryotic vector;(ii) detecting a perfect oligo repeat at an end of the starting phage genome and selecting a oligonucleotide duplex comprising a sequence homologous to the starting phage genome and a sequence homologous to the eukaryotic vector; (c) introducing the starting phage genome and the eukaryotic vector of step (a), and the stitching oligonucleotide or the oligonucleotide duplex of step (b) into a plurality of eukaryotic vector host cells that are not phage host cells; (d) selecting a vector host cell comprising a recombinant vector comprising an intact starting phage genome as a result of insertion of the starting phage genome into the vector; and (e) inserting a heterologous nucleic acid sequence comprising an open reading frame encoding a screenable marker into the intact starting phage genome to provide a recombinant intact phage genome, wherein the screenable marker is operatively linked to a regulatory control sequence.
地址 Cambridge MA US